FDA Inspection 858296 — New York Reproductive Wellness Medicine, P.C.

New York Reproductive Wellness Medicine, P.C. — FEI 3010122933

The FDA completed an inspection of New York Reproductive Wellness Medicine, P.C. on December 10, 2013 in Syosset, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 10, 2013
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Syosset, NY (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1223021 CFR 1271.50(a)Responsible person to determine, document
1224721 CFR 1271.55(d)(2)Accurate, indelible, legible
1249221 CFR 1271.85(a)Infection with communicable disease agents